Adar1-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
198
Total Value
523731625
Accession Number
0001940272-25-000003
Form Type
13F-HR
Manager Name
Adar1-Capital-Management
Data Enrichment
82% identified
163 identified35 unidentified

Holdings

198 positions
Manager:
Search and click to pin securities to the top
Page 6 of 10
ELI LILLY & Co
Shares:600
Value:$495.5K
MADRIGAL PHARMACEUTICALS, INC.
Shares:1.5K
Value:$493.5K
Vaxcyte, Inc.
Shares:12.8K
Value:$483.3K
RenovoRx, Inc.
Shares:479.9K
Value:$475.1K
Alector, Inc.
Shares:380.3K
Value:$467.8K
INSMED Inc
Shares:6.1K
Value:$463.4K
BioNTech SE
Shares:5.0K
Value:$455.3K
Cidara Therapeutics, Inc.
Shares:20.9K
Value:$451.0K
TENAX THERAPEUTICS, INC.
Shares:68.7K
Value:$450.3K
Edgewise Therapeutics, Inc.
Shares:20.0K
Value:$440.0K
G6363K106
Shares:39.9K
Value:$436.9K
GERON CORP
Shares:266.2K
Value:$423.2K
Instil Bio, Inc.
Shares:24.3K
Value:$422.3K
KalVista Pharmaceuticals, Inc.
Shares:35.7K
Value:$412.5K
Apellis Pharmaceuticals, Inc.
Shares:17.0K
Value:$371.8K
ARGENX SE
Shares:600
Value:$355.1K
Third Harmonic Bio, Inc.
Shares:100.0K
Value:$347.0K
INTUITIVE SURGICAL INC
Shares:700
Value:$346.7K
BIOMARIN PHARMACEUTICAL INC
Shares:4.9K
Value:$346.4K
Dianthus Therapeutics, Inc. /DE/
Shares:18.3K
Value:$331.7K